We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.68 | 0.70% | 98.18 | 426 | 09:05:19 |
From May 2019 to May 2024
Todd Chermak is Abbott's head of innovation and development for emerging markets. "Drug Makers Find 'Branded Generics' Are a Source for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark in the 24th paragraph. (Oct. 23)
(END) Dow Jones Newswires
October 23, 2017 11:11 ET (15:11 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
